vs
Side-by-side financial comparison of ACADIA PHARMACEUTICALS INC (ACAD) and Alarm.com Holdings, Inc. (ALRM). Click either name above to swap in a different company.
ACADIA PHARMACEUTICALS INC is the larger business by last-quarter revenue ($284.0M vs $261.7M, roughly 1.1× Alarm.com Holdings, Inc.). ACADIA PHARMACEUTICALS INC runs the higher net margin — 96.3% vs 13.2%, a 83.1% gap on every dollar of revenue. On growth, ACADIA PHARMACEUTICALS INC posted the faster year-over-year revenue change (9.4% vs 8.0%). Over the past eight quarters, ACADIA PHARMACEUTICALS INC's revenue compounded faster (17.5% CAGR vs 8.3%).
Acadia Pharmaceuticals Inc. is a biopharmaceutical company headquartered in Del Mar, San Diego, California.
Alarm.com, Inc. is an American technology company that provides cloud-based services for remote control, home automation, and alarm monitoring services. The company was founded in 2000 as a spinoff from MicroStrategy. The company is based in Tysons, Virginia.
ACAD vs ALRM — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $284.0M | $261.7M |
| Net Profit | $273.6M | $34.6M |
| Gross Margin | 90.8% | 66.0% |
| Operating Margin | 6.1% | 13.4% |
| Net Margin | 96.3% | 13.2% |
| Revenue YoY | 9.4% | 8.0% |
| Net Profit YoY | 90.3% | 14.8% |
| EPS (diluted) | $1.61 | $0.66 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $284.0M | $261.7M | ||
| Q3 25 | $278.6M | $256.4M | ||
| Q2 25 | $264.6M | $254.3M | ||
| Q1 25 | $244.3M | $238.8M | ||
| Q4 24 | $259.6M | $242.2M | ||
| Q3 24 | $250.4M | $240.5M | ||
| Q2 24 | $242.0M | $233.8M | ||
| Q1 24 | $205.8M | $223.3M |
| Q4 25 | $273.6M | $34.6M | ||
| Q3 25 | $71.8M | $35.1M | ||
| Q2 25 | $26.7M | $34.2M | ||
| Q1 25 | $19.0M | $27.7M | ||
| Q4 24 | $143.7M | $30.1M | ||
| Q3 24 | $32.8M | $36.7M | ||
| Q2 24 | $33.4M | $33.5M | ||
| Q1 24 | $16.6M | $23.6M |
| Q4 25 | 90.8% | 66.0% | ||
| Q3 25 | 92.2% | 65.8% | ||
| Q2 25 | 92.2% | 65.6% | ||
| Q1 25 | 91.7% | 67.2% | ||
| Q4 24 | 91.6% | 65.5% | ||
| Q3 24 | 92.5% | 64.8% | ||
| Q2 24 | 92.5% | 65.2% | ||
| Q1 24 | 88.8% | 65.7% |
| Q4 25 | 6.1% | 13.4% | ||
| Q3 25 | 12.8% | 14.4% | ||
| Q2 25 | 12.2% | 12.6% | ||
| Q1 25 | 7.9% | 12.4% | ||
| Q4 24 | 59.1% | 12.7% | ||
| Q3 24 | 12.6% | 13.8% | ||
| Q2 24 | 12.6% | 11.0% | ||
| Q1 24 | 7.4% | 8.4% |
| Q4 25 | 96.3% | 13.2% | ||
| Q3 25 | 25.8% | 13.7% | ||
| Q2 25 | 10.1% | 13.5% | ||
| Q1 25 | 7.8% | 11.6% | ||
| Q4 24 | 55.4% | 12.4% | ||
| Q3 24 | 13.1% | 15.3% | ||
| Q2 24 | 13.8% | 14.3% | ||
| Q1 24 | 8.0% | 10.6% |
| Q4 25 | $1.61 | $0.66 | ||
| Q3 25 | $0.42 | $0.65 | ||
| Q2 25 | $0.16 | $0.63 | ||
| Q1 25 | $0.11 | $0.52 | ||
| Q4 24 | $0.86 | $0.56 | ||
| Q3 24 | $0.20 | $0.67 | ||
| Q2 24 | $0.20 | $0.62 | ||
| Q1 24 | $0.10 | $0.44 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $177.7M | $960.6M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $1.2B | $848.2M |
| Total Assets | $1.6B | $2.1B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $177.7M | $960.6M | ||
| Q3 25 | $258.0M | $1.1B | ||
| Q2 25 | $253.6M | $1.0B | ||
| Q1 25 | $217.7M | $1.2B | ||
| Q4 24 | $319.6M | $1.2B | ||
| Q3 24 | $155.1M | $1.2B | ||
| Q2 24 | $177.1M | $1.1B | ||
| Q1 24 | $204.7M | $747.9M |
| Q4 25 | $1.2B | $848.2M | ||
| Q3 25 | $917.3M | $827.2M | ||
| Q2 25 | $822.4M | $797.3M | ||
| Q1 25 | $765.2M | $759.6M | ||
| Q4 24 | $732.8M | $726.5M | ||
| Q3 24 | $577.2M | $690.3M | ||
| Q2 24 | $516.7M | $645.5M | ||
| Q1 24 | $464.0M | $728.1M |
| Q4 25 | $1.6B | $2.1B | ||
| Q3 25 | $1.3B | $2.1B | ||
| Q2 25 | $1.2B | $2.1B | ||
| Q1 25 | $1.1B | $2.1B | ||
| Q4 24 | $1.2B | $2.0B | ||
| Q3 24 | $976.9M | $2.0B | ||
| Q2 24 | $914.1M | $1.9B | ||
| Q1 24 | $855.1M | $1.5B |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-48.7M | $35.9M |
| Free Cash FlowOCF − Capex | — | $35.1M |
| FCF MarginFCF / Revenue | — | 13.4% |
| Capex IntensityCapex / Revenue | — | 0.3% |
| Cash ConversionOCF / Net Profit | -0.18× | 1.04× |
| TTM Free Cash FlowTrailing 4 quarters | — | $137.0M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-48.7M | $35.9M | ||
| Q3 25 | $74.3M | $70.6M | ||
| Q2 25 | $64.0M | $22.7M | ||
| Q1 25 | $20.3M | $24.1M | ||
| Q4 24 | $40.4M | $56.3M | ||
| Q3 24 | $63.2M | $77.3M | ||
| Q2 24 | $25.0M | $23.0M | ||
| Q1 24 | $29.1M | $49.9M |
| Q4 25 | — | $35.1M | ||
| Q3 25 | $73.9M | $65.9M | ||
| Q2 25 | — | $18.2M | ||
| Q1 25 | — | $17.9M | ||
| Q4 24 | — | $54.0M | ||
| Q3 24 | $63.2M | $74.5M | ||
| Q2 24 | — | $21.0M | ||
| Q1 24 | — | $46.8M |
| Q4 25 | — | 13.4% | ||
| Q3 25 | 26.5% | 25.7% | ||
| Q2 25 | — | 7.1% | ||
| Q1 25 | — | 7.5% | ||
| Q4 24 | — | 22.3% | ||
| Q3 24 | 25.2% | 31.0% | ||
| Q2 24 | — | 9.0% | ||
| Q1 24 | — | 21.0% |
| Q4 25 | — | 0.3% | ||
| Q3 25 | 0.1% | 1.9% | ||
| Q2 25 | — | 1.8% | ||
| Q1 25 | — | 2.6% | ||
| Q4 24 | — | 0.9% | ||
| Q3 24 | 0.0% | 1.2% | ||
| Q2 24 | — | 0.9% | ||
| Q1 24 | — | 1.4% |
| Q4 25 | -0.18× | 1.04× | ||
| Q3 25 | 1.03× | 2.01× | ||
| Q2 25 | 2.40× | 0.66× | ||
| Q1 25 | 1.07× | 0.87× | ||
| Q4 24 | 0.28× | 1.87× | ||
| Q3 24 | 1.93× | 2.11× | ||
| Q2 24 | 0.75× | 0.69× | ||
| Q1 24 | 1.76× | 2.11× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ACAD
| Nuplazid | $174.4M | 61% |
| Daybue | $109.6M | 39% |
ALRM
| License And Service | $180.2M | 69% |
| Hardwareand Other Revenue | $81.4M | 31% |
